|
1.
|
Muehlschlegel S, Rordorf G, Sims J. Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study. Stroke. 2011 May; 42(5):1301-6.
|
|
|
|
|
2.
|
Muehlschlegel S, Selb J, Patel M, Diamond SG, Franceschini MA, Sorensen AG, Boas DA, Schwamm LH. Feasibility of NIRS in the neurointensive care unit: a pilot study in stroke using physiological oscillations. Neurocrit Care. 2009; 11(2):288-95.
|
|
|
|
|
3.
|
Muehlschlegel S, Voetsch B, Sorond FA. Emergent epidural blood patch: lifesaving treatment of paradoxical herniation. Arch Neurol. 2009 May; 66(5):670-1.
|
|
|
|
|
4.
|
Muehlschlegel S, Sims JR. Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit. Neurocrit Care. 2009; 10(1):103-15.
|
|
|
|
|
5.
|
Muehlschlegel S, Rordorf G, Bodock M, Sims JR. Dantrolene mediates vasorelaxation in cerebral vasoconstriction: a case series. Neurocrit Care. 2009; 10(1):116-21.
|
|
|
|
|
6.
|
Muehlschlegel S, Goddeau RP, Sims JR. Teaching NeuroImage: Cerebral T-waves from an aneurysmal cardunculus compression. Neurology. 2008 Feb 12; 70(7):e28-9.
|
|
|
|
|
7.
|
Muehlschlegel S, Voetsch B, Singhal AB. CT angiography and CT perfusion in post-CEA hyperperfusion syndrome. Neurology. 2007 Apr 24; 68(17):1437.
|
|
|
|
|
8.
|
Muehlschlegel S, Dunser MW, Gabrielli A, Wenzel V, Layon AJ. Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage. Neurocrit Care. 2007; 6(1):3-10.
|
|
|
|
|
9.
|
Muehlschlegel S, Lobato EB. Con: all cardiac surgical patients should not have intraoperative cerebral oxygenation monitoring. J Cardiothorac Vasc Anesth. 2006 Aug; 20(4):613-5.
|
|
|
|
|
10.
|
Muehlschlegel S, Okun MS, Foote KD, Coco D, Yachnis AT, Fernandez HH. Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder. Mov Disord. 2005 Nov; 20(11):1523-7.
|
|
|
|
